Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 346-348, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diver, M. J.
Right arrow Articles by Fahie-Wilson, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diver, M. J.
Right arrow Articles by Fahie-Wilson, M. N.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:346-348.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

An Unusual Form of Big, Big (Macro) Prolactin in a Pregnant Patient

Michael J. Diver1,a, David L. Ewins2, Richard C. Worth2, Shirley Bowles2, James A. Ahlquist3 and Michael N. Fahie-Wilson3

1 Department of Clinical Chemistry, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, United Kingdom

2 Countess of Chester Hospital, Liverpool Road, Chester, United Kingdom

3 Southend Hospital, Westcliffe-on-Sea, Essex SS0 0RY, United Kingdom
a author for correspondence: fax 44-151-706-5813, e-mail mjdiver@liv.ac.uk.


   Introduction
 
It is well recognized that circulating prolactin may exist in several forms, including little (monomeric), big, and big, big (macroprolactin) prolactin with molecular masses of 23, 50, and 150–170 kDa, respectively (1).

We report the case of a 30-year-old woman who initially attended her primary care physician because of the onset of painful irregular periods. Her cycle usually was regular, but she had had an 8-week interval of amenorrhea, followed by a particularly painful bleed for which she sought medical advice. Before this, and subsequently, her menstruation had been completely regular with a 28-day cycle. She had no other problems.

The patient’s initial serum prolactin was recorded as 15 800 mIU/L (~530 µg/L) in a Bayer Immuno 1TM assay (Bayer Corporation). Other investigations at the time were entirely normal.

When the subject was monitored 2 months later, she was symptomless and menstruating regularly; her serum prolactin, using the same assay as before, was 8440 mIU/L (~270 µg/L). Pituitary imaging by magnetic resonance was normal. She had, of choice, never been pregnant.

Because of the patient’s lack of symptoms, normal pituitary imaging, and regular cycles, further analytical investigations were carried out on a sample of her serum. After polyethylene glycol (PEG) precipitation, the recovery of prolactin was low, indicating the presence of macroprolactin (2), and 15% of her total prolactin was estimated to be monomeric prolactin.

The . . . [Full Text of this Article]


   References
 



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
C. Hekim, H. Alfthan, J. T. Leinonen, and U.-H. Stenman
Effect of Incubation Time on Recognition of Various Forms of Prolactin in Serum by the DELFIA Assay
Clin. Chem., December 1, 2002; 48(12): 2253 - 2256.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.